Powerful directed evolution methods have been developed for tailoring proteins to our needs in industrial applications. Here, the authors report a medium-throughput assay system designed for screening mutant libraries of oxygenases capable of inserting a hydroxyl group into a C-H bond of aromatic or O-heterocyclic compounds and for exploring the substrate profile of oxygenases. The assay system is based on 4-aminoantipyrine (4-AAP), a colorimetric phenol detection reagent. By using 2 detection wavelengths (509 nm and 600 nm), the authors achieved a linear response from 50 to 800 µM phenol and standard deviations below 11% in 96-well plate assays. The monooxygenase P450 BM-3 and its F87A mutant were used as a model system for medium-throughput assay development, identification of novel substrates (e.g., phenoxytoluene, phenylallyether, and coumarone), and discovery of P450 BM-3 F87A mutants with 8-fold improvement in 3-phenoxytoluene hydroxylation activity. This activity increase was achieved by screening a saturation mutagenesis library of amino acid position Y51 using the 4-AAP protocol in the 96-well format. (Journal of Biomolecular Screening 2005:246-252) 
INTRODUCTION
I NSERTING OXYGEN FROM MOLECULAR OXYGEN into C-H bonds is a very attractive reaction for the synthesis of fine chemicals, pharmaceuticals, and other applications in pollution management and oil refinement. 1 The major limitations for using biocatalysts for these reactions types are their often insufficient activity toward nonnatural substrates and their often low thermal and organic solvent resistance. 2, 3 A further serious bottleneck in this area of research has been the lack of robust screening systems that employ in directed evolution experiments directly the substrates of interest and not colorimetric or fluorimetric model substrates. For the detection of hydroxylated aromatic and O-heterocyclic compounds, various colorimetric and fluorimetric assay systems have been developed, 4 but only the Gibbs assay has, to our knowledge, been used to improve the activity of toluene dioxygenase toward 4picoline. 5, 6 For developing a broad screening platform for hydroxylated aromatic and O-heterocyclic compounds, we selected the 4aminoantipyrine (4-AAP) assay and the monooxygenase P450 BM-3 (CYP102) from Bacillus megaterium. 4-Aminoantipyrine assay is an old detection system developed by Emerson. 7 In the 1950s, Ettinger and coworkers 8 used the 4-aminoantipyrine assay for quantifying µg/L levels of phenol in water. A phenol-4aminoantipyrine dye complex is formed by an oxidative coupling reaction mechanism, 9 leading to a p-quinoid species. 10 The extended conjugated system causes the color change. The 4-AAP assay system was in the presence of superior "biological materials" in terms of sensitivity and standard deviation compared to all investigated colorimetric assays (Gibbs reagent, Folin-Ciocalteus reagent, Liebermann reaction, diazocompounds [Fast Violet B, Fast Blue BB, Fast Black K], anisaldehyde/H 2 SO 4 , and diammoniumhexanitratocerate [(NH 4 ) 2 Ce(NO 3 ) 6 ]). P450 BM-3 is a water-soluble heme enzyme of M r 118 kDa that contains the heme domain and reductase domain on a single polypeptide chain. 11, 12 It was isolated from Bacillus megaterium, cloned, and functionally expressed in various Escherichia coli strains. 11,12 P450 BM-3 was selected due to its broad substrate profile. P450 BM-3 and various engineered mutants catalyze the terminal and subterminal hydroxylation of short-, medium-, and long-chain fatty acids and alkanes, the epoxidation of mediumand long-chain unsaturated fatty acids, and the hydroxylation of polyaromatic compounds and heteroarenes. [13] [14] [15] [16] [17] [18] [19] [20] [21] Numerous P450 BM-3 reaction products, such as indigo, catechols, and hydroxylated alkanes, have a significant market value. Their k cat is 10-to 1000-fold higher than those of many eukaryotic fatty acid hydroxylases (e.g., members of the CYP52 or CYP4 families 22 ). E. coli cells expressing P450 BM-3 have been used as whole-cell catalysts to produce mixtures of chiral 12-, 13-, and 14-hydroxypentadecanoic acid with high optical purity. 23 Furthermore, P450 BM-3 can efficiently be purified on a preparative scale using a single-step purification method. 24 Here we describe a screening platform for a broad range of aromatic and O-heterocyclic substrates, which, in terms of sensitivity and linear detection range, are superior to previously reported systems. The screening platform was validated in a medium-throughput format for identifying novel substrates and improving the activity of P450 BM-3 F87A toward 3-phenoxytoluene by 8-fold.
MATERIALS AND METHODS
All chemicals used were of analytical reagent grade or higher quality and purchased from Sigma-Aldrich Chemie (Taufkirchen, Germany), Applichem (Darmstadt, Germany), and Carl Roth (Karlsruhe, Germany).
A thermal cycler (Mastercycler gradient; Eppendorf, Hamburg, Germany) and thin-wall PCR tubes (Mµlti-Ultra tubes; 0.2 mL; Carl Roth, Germany) were used in all PCRs. The PCR volume was always 50 µL; larger volumes were prepared in multiple 50-µL PCRs. The amount of DNA was quantified using a NanoDrop photometer (NanoDrop Technologies, Wilmington, DE).
Saturation mutagenesis at position Y51 of P450 BM-3 F87A in pCYTEXP1 25
The saturation mutagenesis library of P450 BM-3 F87A was created by employing the following modified QuikChange protocol (Stratagene). For the mutagenic PCR (95°C for 4 min, 1 cycle; 95°C for 90 s/62°C for 75 s/68°C for 17 min, 20 cycles; 68°C for 17 min, 1 cycle), 3.125 U Pfu DNA polymerase (Fermentas, St. Leon-Rot, Germany), 0.25 mM dNTP mix (New England Biolabs, Frankfurt, Germany), 17.5 pmol of each primer (5′-CCTGGTCGTGTAACGCGCNNNTTACAAGTCAGC-3′/5′-GCTGACTTGATAANNNGCGCGTTACACGACCAGG-3′), and 35 ng of template (pCYTEXP1 25 harboring P450 BM-3 F87A gene) were used. Then, 40 U of DpnI (New England Biolabs) were added after PCR and incubated for 3 to 4 h at 37°C. The PCR product was purified using NucleoSpin Extract (Machery-Nagel, Düren, Germany) and transformed into E. coli XL2 Blue. The plasmid library was isolated by resuspending~400 colonies from the LB amp plate in 1 mL LB media and using the QIAprep Miniprep Kit (Qiagen, Hilden, Germany). Following digestion with 20 U of each BamHI (New England Biolabs) and EcoRI (New England Biolabs), the genes were subcloned after gel extraction (QIAquick Gel Extraction Kit, Qiagen) into the pCWori vector and transformed into E. coli DH5α using the TSS method. 26
Cultivation and expression of P450 BM-3 in 96-deep well plates
Colonies on LB amp plates were picked using toothpicks and transferred to 96-well microplates containing 150 µL LB amp media.
After growing overnight in a microplate shaker (Multitron II, Infors GmbH, Einsbach, Germany; 37°C, 990 rpm and 70% humidity),~5 µL of each culture was transferred with System Duetz (Kühner, Birsfelden, Switzerland) into 2-mL deep-well plates containing 600 µL of enriched TB amp medium. TB amp solution was supplemented with isopropyl-β-D-thiogalactoside (IPTG, 100 µM), δ-aminolevulinic acid anhydride (ALA, 0.5 mM), and 0.6 µL trace element solution (0. , 500 rpm for 24 h) and harvested by transferring 400-µL cultures into 96-well V-bottomed microplates using a liquid-handling machine (Multimek ™ 96 Beckman, Fullerton, CA). After centrifugation (4°C, 3220 g for 15 min), the supernatant was discarded, and the cell pellets were frozen at -20°C overnight.
Preparation of cell lysate for screening
Each cell pellet in the 96-well V-bottomed microplate was resuspended in 140 µL lysomix (5 mg/mL lysozyme in 50 mM, pH 7.5, potassium phosphate buffer). The plates were incubated for 1 h at 37°C.
96-well plate assays

Linear detection range of 4-aminoantipyrine assay for phenol
Phenol was used as model substrate for hydroxylated aromatic compounds to determine the linear detection range under screening conditions in the 96-well format. Various concentrations of phenol (0-1.2 mM final concentration) were pipetted into 180 µL of phosphate buffer (KxPO 4 , 50 mM, pH 7.5). A solution consisting of 35 µL quenching buffer (4 M urea and 0.1 M NaOH) was immediately added. After supplementing 15 µL 4aminoantipyrine (4-AAP, 5 mg/mL), 15 µL potassium peroxodisulfate (5 mg/mL), and incubating for 30 min at room temperature, the bubbles were removed using a Bunsen burner, and absorbance was measured at 509 nm and 600 nm to quantify the phenol concentration using a FLASHScan S12 microplate reader (Analytik Jena AG, Jena, Germany; Fig. 2 ).
Standard deviation of 4-aminoantipyrine assay for 11-phenoxyundecanoic acid using P450 BM-3 in 96-well format E. coli DH5α expressing P450 BM-3 was cultured and lysed as previously described in the 96-well plate format. Then, 120 µL of the lysed cell suspension containing expressed P450 BM-3 was transferred into a 96-well V-bottomed microplate containing 95 µL phosphate buffer (KxPO 4 , 50 mM, pH 7.5) and supplemented with 5 µL 11-phenoxyundecanoic acid (100 mM, dissolved in DMSO). Reaction was initiated upon addition of 20 µL NADPH (5 mM). The reaction mixture was incubated for 1 h at room tem-Assay for Hydroxylases perature and centrifuged (4°C, 3220g for 15 min), and 180 µL of the supernatant was transferred into a new 96-well flat-bottomed microplate. Reaction was quenched upon addition of 35 µL quenching buffer (4 M urea and 0.1 M NaOH). After adding 15 µL 4-AAP (5 mg/mL), 15 µL potassium peroxodisulfate (5 mg/mL), and incubating for 30 min at room temperature, the bubbles were removed using a Bunsen burner, and absorbance was measured at 509 nm and 600 nm using a microplate reader (FLASHScan S12, Analytik Jena AG). Apparent standard deviation was calculated based on absorbance values obtained. The whole procedure was repeated using lysed cell suspension without P450 BM-3 protein.
Absorbance values obtained were considered as background absorbance. "True" standard deviation was calculated after subtracting the background absorbance.
Application of the 4-aminoantipyrine assay
Identification of novel substrates. The screening procedure was identical to the 96-well activity assay for 11-phenoxyundecanoic acid, except that the reaction mixture was supplemented with potential substrates (see Table 1 ; 3-5 µL of 1-100 mM substrates dissolved in DMSO), and the P450 BM-3 F87A mutant was used. F87A mutant was selected due to space consideration. After replacing the bulky phenylalanine by alanine, additional space was created in the binding pocket to accommodate sterically demanding compounds such as aromatic and O-heterocyclic compounds. 18 Increasing P450 BM-3 F87A activity toward 3-phenoxytoluene using saturation mutagenesis library at position Y51. The screening procedure was identical to the 96-well activity assay for 11phenoxyundecanoic acid, except that the reaction mixture was supplemented with 5 µL of 3-phenoxytoluene (100 mM, dissolved in DMSO).
Expression and purification of P450 BM-3 variants in shaking flask
The 250-mL TB amp media, supplemented with the 250-µL trace element solution (composition as described above), were inoculated with 250 µL overnight culture (E. coli DH5α/pCWori). ALA (0.5 mM) was added, and expression was induced by addition of IPTG (100 µM) after cultivation for 10 h (35°C, 250 rpm, Infors MultitronII). Cells were harvested after an additional cultivation time of 20 h (35°C, 250 rpm, Infors MultitronII). P450 BM-3 F87A and the mutants (Y51F, Y51L, Y51I) were purified, 24 and monooxygenase concentrations were determined by COdifference spectra, as reported by Omura and Sato, 27 using ε = 91 mM -1 cm -1 .
Determination of initial NADPH consumption rates
Initial rates of hydroxylation were determined using the 4-AAP assay and correlated to initial NADPH consumption rates using a UV-vis spectrophotometer (SPECORD200; Analytik Jena AG) and cuvettes (1.5-mL semi-micro PMMA PLASTIBRAND, BRAND, Wertheim, Germany). A reaction mixture contains 790 µL phosphate buffer (KxPO 4 , 50 mM, pH 7.5), 10 µL 3phenoxytoluene (100 mM, dissolved in DMSO), and 100 µL purified monooxygenase solution. Reactions were initiated after a 5min incubation time by the addition of 100 µL NADPH (5 mM). NADPH consumption rates were recorded at 340 nm, and the background reaction was determined by recording NADPH consumption rates of purified P450 BM-3 variants 24 in the absence of the 3-phenoxytoluene substrate.
RESULTS
We aimed to extend the phenolic 4-AAP detection system into a screening platform for aromatic and O-heterocyclic compounds. In the 1st step, we downscaled the 4-AAP assay for use in the 96well format, employing 11-phenoxyundecanoic acid as the model substrate. Upon terminal hydroxylation, 11-phenoxyundecanoic acid decomposes at room temperature into the 4-AAP detectable phenol and ω-oxyundecanoic acid (Fig. 1A) . Standard deviations have been reduced by optimizing growth conditions (various shaking speed [200-1000 rpm] and culture volumes [200, 300, 400, 500, and 600 µL]). The preferred combination of 600 µL TB media in 2-mL deep-well plates at 500 rpm in a microplate shaker resulted in a true standard deviation of 10.6% after subtracting the background (Fig. 1B) . Screening systems with standard deviations around 10% have successfully been used in directed evolution experiments. 3, 17 In the 2nd step, we extended the linear detection range of the 4-AAP assay by using 2 detection wavelengths, 509 and 600 nm 
-Picoline Toluene
The compounds on the left-hand side showed a low but detectable activity in the 96-well format and are sorted by decreasing 4-AAP detectable activity. The compounds on the right-hand side did not show a 4-AAP detectable activity in the 96-well assay and are sorted in alphabetical order.
( Fig. 2) . A wide linear detection window is important for identifying, in directed evolution experiments, beneficial mutants, and screening systems for evolved mutants have to be constantly adapted for hitting the linear detection window. By adding a 2nd wavelength (600 nm), we significantly enlarged the linear detection window from 50-250 µM to 50-800 µM (Fig. 2) . In the 3rd step, we validated the medium-throughput screening system by identifying novel substrates for P450 BM-3 F87A and improving the activity toward a novel substrate by screening a saturation mutagenesis library of position 51. Inspired by the fatty acids that are regarded as the natural P450 BM-3 substrates, 24 compounds were selected based on different side chains (length and charge) and sterical demands (substituted benzenes to anthracene). For screening in 96-well plates, 3 different mM concentrations of substrates were used, employing DMSO as cosolvent. The cosolvent DMSO allows us to dissolve the selected compounds in concentrations between 1 and 100 mM without affecting the P450 BM-3 F87A stability. 3 This is an important prerequisite for achieving turnover because previous studies on nonnatural substrates 13, 18 Assay for Hydroxylases often revealed K m values of P450 BM-3 in the mM range. Ten out of the 24 investigated compounds showed a low 4-AAP detectable activity in the 96-well format ( Table 1) .
3-Phenoxytoluene was selected as novel substrate for improving P450 BM-3 F87A activity. The true standard deviation of 3phenoxytoluene using the 4-AAP assay was beyond 20%. Instead of using directed evolution, we decided to go for a semirational design approach to increase activity. Our modeling studies indicated that position 51 in P450 BM-3 might play a key role for substrate access toward the heme. We therefore saturated position 51 and screened the library for 3-phenoxytoluene activity. The best mutants were sequenced, revealing 3 different mutations at position Y51 (Y51I, Y51L, Y51F). In all cases, the tyrosine was replaced by a hydrophobic amino acid. The 3 mutants were expressed, purified using standard protocols, 24 and investigated in detail. After CO normalization, a size-dependent activity increase of up to 8-fold was observed (Table 2 ) and confirmed in NADPH consumption assays. The expression levels in the 250-mL shaking flask cultures varied less than 20% for F87A and the 3 mutants.
DISCUSSION
Directed evolution was especially successful in cases in which the screening conditions were close to application conditions. We aimed to develop a screening platform that allows evolving oxygenases directly on the target compound and that can be used for a broad range of aromatic and O-heterocyclic compounds (platform idea). Such a screening system for hydroxylated aromatic and O-hetercyclic compounds has, to our knowledge, not been reported yet. After optimizing cultivation and screening conditions, a sensitive 4-AAP-based screening system with a wide linear detection range from 50 to 800 µM was developed. The 4-AAP system allows, in contrast to many other screening systems, improvement in the activity of the monooxygenase directly on a broad range of different target compounds and is not limited to surrogate substrates. [28] [29] [30] Directed evolution assays employing surrogate substrates are often best used to improve or study properties such as organic solvent resistance or thermal stability. 3, 31 To validate the screening system, we screened a substrate library to identify novel substrates for the monooxygenase P450 BM-3 F87A and improved the activity of this monooxygenase toward one of the identified substrates. Impressively, 10 out of 24 investigated compounds showed, in the 96-well plate assay, a detectable activity using the 4-AAP protocol. Based on our modeling studies, a saturation mutagenesis library of P450 BM-3 at position 51 was created and screened for the novel substrate 3phenoxytoluene. Position Y51 is known to play a key role in binding and orienting fatty acids toward the catalytic heme center. 32 For all improved and sequenced mutants, the tyrosine at position 51 was replaced by a hydrophobic amino acid: Y51I, Y51L, and Y51F. Interestingly, the turnover numbers increase in good accordance with the size of the amino acid side chain ( Table 2 ). The most active mutant Y51F was 8 times more active than P450 BM-3 F87A and differs only in the hydroxyl-group of the aromatic side chain (Fig. 3) . The hydroxyl-group and the size demand of the side chain therefore play pivotal roles for heme access and turnover of 3-phenoxytoluene. The standard deviation for 3-phenoxytoluene was reduced to~12% for the Y51F mutant and will likely enable further directed evolution studies. Currently, we are collaborating to analyze the size aspect and the effect of the hydrogen bond at po-
FIG. 3.
Illustration of the substrate binding pocket with the 3phenoxytoluene substrate and the position tyrosine 51 that modulates the turnover rates of 3-phenoxytoluene. 3-Phenoxytoluene was docked into the crystal structure of P450 BM-3 (pdb code 1BU7) by manual positioning in the access channel to the active site and near the tyrosine 51 residue. The resulting structure was energy minimized in vacuum by performing 100 steps of the steepest descend method. All energy minimizations were performed using the GROMACS package with the GROMOS96 force field. The picture was obtained from the minimized complex using the program VMD (Visual Molecular Dynamics). The expression levels of P450 BM-3 F87A and the Y51 mutants varied less than 20% before CO normalization. a. Activity of F87A is set as 1.0. sition Y51 to understand structure-function relationships. Further efforts are focusing on determining the regioselectivity and stereoselectivity of Y51F mutant toward 3-phenoxytoluene and other identified P450 BM-3 F87A substrates. In the long run, we aim to establish a monooxygenase platform for industrial application that can rapidly improve and tailor a monooxygenase catalyst toward a broad range of compounds. The 4-AAP assay represents, in this regard, an important prerequisite for improving monooxygenase activities toward aromatic and Oheterocyclic substrates.
